What is Novo Nordisk A/S's EV/EBITDA?

Novo Nordisk A/S (NVO) EV/EBITDA is 7.53x based on the latest available daily valuation data on Chartloom.

How to interpret EV/EBITDA for Novo Nordisk A/S?

Interpreting EV/EBITDA for Novo Nordisk A/S depends on industry, growth expectations, profitability, and peer multiples.

How do you interpret EV/EBITDA?

Lower multiples may indicate better value relative to operating cash earnings.

What should investors consider when analyzing EV/EBITDA?

Industry capital intensity heavily influences typical ranges.

Novo Nordisk A/S

$NVO

Health Care · Pharmaceuticals

IR Run Scenarios

Browse other companiesFree AI scores and summaries for more stocks

Novo Nordisk A/S

$NVO

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Novo Nordisk A/S (NVO) EV/EBITDA: 7.53x

Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.

Latest EV/EBITDA

7.53x

As of Nov 3, 2026

EV/EBITDA

All ChartsAll Valuation Charts

Explore Novo Nordisk A/S's full valuation history

Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts

Recent EV/EBITDA history

Daily readings for the most recent trading days on record.

Date	EV/EBITDA
Nov 3, 2026	7.53x

How is EV/EBITDA calculated?

EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).

How to interpret EV/EBITDA

Browse other companiesFree AI scores and summaries for more stocks

Overview Charts AI Summary Financials Valuation

Novo Nordisk A/S (NVO) EV/EBITDA: 7.53x

Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.

Latest EV/EBITDA

7.53x

As of Nov 3, 2026

EV/EBITDA

All ChartsAll Valuation Charts

Explore Novo Nordisk A/S's full valuation history

Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts

Recent EV/EBITDA history

Daily readings for the most recent trading days on record.

Date	EV/EBITDA
Nov 3, 2026	7.53x

How is EV/EBITDA calculated?

EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).

How to interpret EV/EBITDA

EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.

Lower multiples may indicate better value relative to operating cash earnings.
Industry capital intensity heavily influences typical ranges.

Frequently asked questions

P/E Ratio Forward P/E Ratio P/FCF Ratio All Valuation Charts

Metric definition

Read the general EV/EBITDA definition, formula, and analyst usage guide.

EV/EBITDA guide

Informational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.

Novo Nordisk A/S

Novo Nordisk A/S

Novo Nordisk A/S (NVO) EV/EBITDA: 7.53x

Explore Novo Nordisk A/S's full valuation history

Novo Nordisk A/S (NVO) EV/EBITDA: 7.53x

Explore Novo Nordisk A/S's full valuation history

What is Novo Nordisk A/S's EV/EBITDA?

How is EV/EBITDA calculated?

How to interpret EV/EBITDA for Novo Nordisk A/S?

How do you interpret EV/EBITDA?

What should investors consider when analyzing EV/EBITDA?

How is EV/EBITDA used in stock analysis?